Koyfin Home > Directory > Health Care > Acorda Therapeutics > Issuance of Common Stock

Acorda Therapeutics Issuance of Common Stock Chart (ACOR)

Acorda Therapeutics annual/quarterly Issuance of Common Stock from 2010 to 2019.
  • Acorda Therapeutics Issuance of Common Stock for the quarter ending December 12, 2019 was $0m a 0.00% decrease of 0m year over year
  • Acorda Therapeutics Issuance of Common Stock for the last 12 months ending June 06, 2020 was $0m a 0.00% decrease of 0m year over year
  • Acorda Therapeutics Annual Issuance of Common Stock for 2019 was $0m a -63,225.00% decrease of -15m from 2018
  • Acorda Therapeutics Annual Issuance of Common Stock for 2018 was $15m a 31.05% increase of 5m from 2017
  • Acorda Therapeutics Annual Issuance of Common Stock for 2017 was $10m a -620.68% decrease of -65m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Issuance of Common Stock Data

12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$2m
06/2018$9m
03/2018$3m
12/2017$3m
09/2017$2m

Annual ACOR Issuance of Common Stock Data

2019$0m
2018$15m
2017$10m
2016$76m
2015$18m
2014$16m
2013$13m
2012$4m
2011$4m
2010$8m